Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep609 | Pituitary and Neuroendocrinology | ECE2020

Biliary stone disease in acromegaly under somatostatinanalogues: A longterm safety study

Prencipe Nunzia , Cuboni Daniela , Bona Chiara , Maria Berton Alessandro , Parasiliti Caprino Mirko , Fenoglio Luigi , Gasco Valentina , Ghigo Ezio , Grottoli Silvia

Introduction: Somatostatin analogues (SSA) are one of the main effective drug used in acromegaly. Sludge and/or cholelithiasis development represents oneof the more common side effect. The aim of the study was to analyze the frequency of biliary adverse events (BAE) and possible predictive factors, to propose a work-up strategy for their management.Method: This is a single centre, longitudinalretrospective study; we enrolled 91 acromegaly patients during...